Please login to the form below

Not currently logged in
Email:
Password:

Astellas appoints new senior VP

Shontelle Dodson also takes on head of Medical Affairs Americas role

AstellasAstellas has appointed Shontelle Dodson as its new senior vice president and head of Medical Affairs Americas (MAA) to lead the strategic direction of its MAA organisation including continued medical support of in-line products, late-stage development compounds and ongoing business evolution across the region.

Dodson has previously led the alignment of medical affairs practices, policies and standards at Astellas, and she has taken on projects such as expanding the Health Economics and Outcomes Research function, pioneered multiple real-world data endeavours and built research partnerships with academic and managed care organisations.

Charlotte Kremer, Astellas’ executive vice president and head of medical affairs, said: “Shontelle has been an integral and formative leader in the building and evolution of the Medical Affairs organisation at Astellas.”

“I’m confident she will make an immediate and positive impact on both the team in the Americas, as well as the patients and partners we serve.”

Dodson has previously worked for Pfizer in various medical affairs leadership roles spanning the urology and respiratory franchises and has served GTx as its vice president of medical affairs.

She has also received multiple awards for leadership and innovation through her career, including the National Healthcare Business Women’s Association Rising Star and the Astellas Vision Award.

19th May 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics